Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma. A proof-of-concept, single-arm, multicenter trial

Hyperimmune plasma from patients convalescing from COVID-19 is a potential treatment for severe COVID-19 in other patients. We conducted a multicenter, one-arm, proof-of-concept interventional study. Patients with COVID-19 with moderate-to-severe acute respiratory distress syndrome, elevated C-react...

Descripción completa

Detalles Bibliográficos
Autores principales: Perotti, Cesare, Baldanti, Fausto, Bruno, Raffaele, Del Fante, Claudia, Seminari, Elena, Casari, Salvatore, Percivalle, Elena, Glingani, Claudia, Musella, Valeria, Belliato, Mirko, Garuti, Martina, Meloni, Federica, Frigato, Marilena, Di Sabatino, Antonio, Klersy, Catherine, De Donno, Giuseppe, Franchini, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716363/
https://www.ncbi.nlm.nih.gov/pubmed/33256382
http://dx.doi.org/10.3324/haematol.2020.261784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716363/
https://www.ncbi.nlm.nih.gov/pubmed/33256382
http://dx.doi.org/10.3324/haematol.2020.261784

Ejemplares similares